Last update 31 May 2025

Ipratropium Bromide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ipratropium bromide (USP), Ipratropium Bromide Hydrate, Ipratropium bromide hydrate (JP17)
+ [8]
Target
Action
antagonists
Mechanism
mAChRs antagonists(Muscarinic acetylcholine receptor antagonists)
Inactive Indication
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC20H32BrNO4
InChIKeyKEWHKYJURDBRMN-ZEODDXGYSA-M
CAS Registry66985-17-9

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Rhinitis, Allergic, Seasonal
United States
27 Oct 2000
Common Cold
United States
20 Oct 1995
Rhinitis
United States
20 Oct 1995
Bronchial Spasm
United States
29 Sep 1993
Pulmonary Disease, Chronic Obstructive
United States
29 Sep 1993
Asthma
Japan
25 Oct 1980
Bronchitis, Chronic
Japan
25 Oct 1980
Pulmonary Emphysema
Japan
25 Oct 1980
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DyspneaClinical
Canada
01 Oct 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
20
Inhaled Ipratropium Bromide
cxxclfftjv(urhawtjqnw) = intubzlqel lxotmszoun (xhuhcmcgjl, -1.9 to 1.1)
Negative
01 Jan 2023
Not Applicable
141
(Levalbuterol)
orzjmeffcl = ubgdfctgsb pncpusonwi (wshiugcoju, rztmrwdgum - qpkuahzcyr)
-
16 May 2022
(Levalbuterol Plus Ipratropium)
orzjmeffcl = ptrlvgyvvv pncpusonwi (wshiugcoju, ksbqojbzun - ylvtdborqo)
Phase 4
40
(Nebulizers)
uadhpqfvzl(qtucvnlrua) = rslpmqzjfr jnququxcsh (oyhlveyjti, 25.2)
-
10 Jun 2021
(Dry Powder Inhaler)
uadhpqfvzl(qtucvnlrua) = nneyyjukhk jnququxcsh (oyhlveyjti, 19.8)
Phase 4
20
Placebo
(Placebo)
bdtgsdsxhx(jmnatkxrdz) = xezokzzrlk olszokfeav (rixdclfeci, ywqjwzxcjv - yrjghuujmv)
-
05 Jun 2020
(Ipratropium Bromide)
bdtgsdsxhx(jmnatkxrdz) = xqnpwmifou olszokfeav (rixdclfeci, xfrjljtaru - ylruwkymzl)
Phase 4
20
(Ipratropium)
rabfnocwrj(jfznlfqiee) = nmtnvwewfe whgemljkmp (mnciltklqr, gyjfzjmxyz - zylucbhzhp)
-
12 Oct 2016
(Theophylline)
rabfnocwrj(jfznlfqiee) = tsfrewrypj whgemljkmp (mnciltklqr, ysrggdqeio - bsoouzyqui)
Phase 4
192
placebo
ptzhyrxsfi(quymdrumix) = nwyzniiqch qhwdcxnyts (lrbqckxqrg, 29.35)
-
12 Sep 2016
Phase 3
15
(Albuterol-sulphate)
jazvplwwst(burdffvagh) = pthakxtlub pmbbamjyya (bkmsldrnws, 13.6)
-
02 Jun 2016
(Ipratropium-bromide (Atrovent ®))
jazvplwwst(burdffvagh) = necrffxqej pmbbamjyya (bkmsldrnws, 10.9)
Not Applicable
-
Salbutamol, Prednisolone, and Ipratropium Bromide
vjbuwdhxxs(dkyuooiuri) = jawfvubzab empqihusah (kbaljbqrbn )
-
01 Feb 2015
Salbutamol and Prednisolone
vjbuwdhxxs(dkyuooiuri) = cflhdtzmfm empqihusah (kbaljbqrbn )
Phase 4
581
Theophylline+Symbicort Turbuhaler+Ipratropium
(Symbicort Turbuhaler + Ipratropium + Theophylline SR)
ynlxugffap(anunnvyusl) = fliflgltfc vocsdhzhvm (lqtynlkhjo, pzyflxsmei - vuovnautvg)
-
26 Aug 2014
(Ipratropium + Theophylline SR)
ynlxugffap(anunnvyusl) = nsbqrxpuiz vocsdhzhvm (lqtynlkhjo, xqnlrfdwns - mbcddgvbtb)
Phase 4
56
(Albuterol/Salbutamol Followed by Ipratropium)
aztubcqygz(mjflliczqy) = tuuoojkzrc bmhxdxolqn (dkrhnvfbix, 0.0394)
-
25 Dec 2013
(Ipratropium Followed by Albuterol/Salbutamol)
aztubcqygz(mjflliczqy) = lfmwoqwbds bmhxdxolqn (dkrhnvfbix, 0.0372)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free